Trials / Unknown
UnknownNCT05188365
Acupuncture Efficacy on Lipids in Tinnitus Patients With Obesity
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 35 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
nowadays, published literature affirms strong relation between tinnitus, obesity, and high lipids of blood.
Detailed description
For 8 weeks, our study will search effect of acupuncture on tinnitus (chronic subjective type), lipids and weight reduction in obese persons.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | true acupuncture | different body acupuncture points will be selected to be manually punctured in addition to 4 acupoints on the skin of abdominal surface (the four points will be electrical stimulated during acupuncture). the session (20 minutes) will repeated thrice weekly. the total duration of the study will be 60 days. The points that will be manually acupunctured all over the body of every patient will be: SJ(3)/SJ(5)/SJ(17)/SJ(18)/SJ(19)/SJ(20)/SJ(21)/SJ(22)/GB(2)/GB(8)/GB(20)/LI(4)/LI(11)/KI(3)/SP(6)/ST(36)/REN(4)/REN(9)/REN(12) The acupuncture points that will be electrically stimulated on the abdomen of every patient will be: bilateral Stomach 25 in addition to gallbladder 28 acupoints. |
| OTHER | sham acupuncture | different body acupuncture points will be selected to be manually punctured in addition to 4 acupoints on the skin of abdominal surface (the four points will be electrical stimulated during acupuncture). opposite to group A, in this group, the acupuncture needles will be inserted manually and very adjacent to the real location of group-A acupoints (sham acupuncture). The electrical stimulator will connected to abdominal acupoints (bilateral Stomach 25 in addition to gallbladder 28 acupoints) but it will be turned off during the sessions. the session will repeated thrice weekly. the total duration of the study will be 60 days |
Timeline
- Start date
- 2021-12-06
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
- First posted
- 2022-01-12
- Last updated
- 2022-01-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05188365. Inclusion in this directory is not an endorsement.